Doug Sheffield

Doug Sheffield is a seasoned expert in clinical and preclinical research, currently serving as the Chief Scientific Officer at Cadence Neuroscience Inc. since May 2017. With a robust background in clinical affairs, Sheffield previously held the position of Executive Director at Spiration, Inc., where responsibilities included leading clinical strategy and ensuring regulatory compliance. At Sheffield Consulting, consulting services focused on preclinical and early-stage medical device companies. Prior roles include VP of Clinical Research at NeuroVista, Director of New Technology at Northstar Neuroscience, and multiple directorships at Ethicon and Ethicon Endo-Surgery. Doug Sheffield holds advanced degrees from The Johns Hopkins University and the University of Pennsylvania, underscoring a strong foundation in veterinary medicine and pathology.